Mukhtar Ahmed Biography and Net Worth

Insider of Clarivate

Mukhtar Ahmed has been President, Science Group of the Company since September 2019. He joined the Company in January 2018 as President of Life Sciences.

He brings with him a wealth of leadership experience, spanning across a 30 year career within the biopharmaceutical, health sciences and technology industries. Mr. Ahmed most recently served as President of eHealth Solutions at Bioclinica where he was responsible for a global business division that provided commercial cloud technologies and specialist services to the biopharmaceutical and medical devices sectors. Prior to that, he was the Global Vice President at Oracle Corporation. He also held senior executive positions with various multinational corporations including Parexel and Kendle International, as well as holding board-level positions with the UK National Health Service (NHS) and a number of venture capital and private equity backed companies.

Mukhtar holds a Bachelor of Science degree with honours in Applied Computer Systems from Brunel University, and a diploma in computing from Buckinghamshire College. Mukhtar is a member of the Royal Society of Medicine, an independent council member for Brunel University and he chaired the Digital Health Committee for Life Sciences PA.

How do I contact Mukhtar Ahmed?: The corporate mailing address for Mr. Ahmed and other Clarivate executives is 160 Blackfriars Road, London X0, SE1 8EZ. Clarivate can also be reached via phone at 442074334000 and via email at [email protected]. Learn More on Mukhtar Ahmed's contact information.
Has Mukhtar Ahmed been buying or selling shares of Clarivate?: Mukhtar Ahmed has not been actively trading shares of Clarivate over the course of the past ninety days. Most recently, Mukhtar Ahmed sold 14,578 shares of the business's stock in a transaction on Wednesday, December 8th. The shares were sold at an average price of $24.80, for a transaction totalling $361,534.40. Learn More on Mukhtar Ahmed's trading history.
Who are Clarivate's active insiders?: Clarivate's insider roster includes Mukhtar Ahmed (Insider), Richard Hanks (CFO), Richard Roedel (Director), Saurabh Saha (Director), James Samson (Insider), Andrew Snyder (Director), Bar Veinstein (Insider), and Sheryl von Bluchder (Director). Learn More on Clarivate's active insiders.
Are insiders buying or selling shares of Clarivate?: In the last year, Clarivate insiders bought shares 1 times. They purchased a total of 28,938 shares worth more than $158,869.62. In the last year, insiders at the sold shares 3 times. They sold a total of 197,646 shares worth more than $1,379,110.50. The most recent insider tranaction occured on October, 15th when insider Bar Veinstein sold 60,000 shares worth more than $420,000.00. Insiders at Clarivate own 23.1% of the company. Learn More about insider trades at Clarivate.
Information on this page was last updated on 10/15/2024.

Mukhtar Ahmed Insider Trading History at Clarivate

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/8/2021	Sell	14,578	$24.80	$361,534.40

Mukhtar Ahmed Buying and Selling Activity at Clarivate

Clarivate Company Overview

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Today's Range

Now: $5.09

$4.86

$5.22

50 Day Range

MA: $6.24

$4.33

$7.10

2 Week Range

Now: $5.09

$4.25

$9.60

Volume

8,939,178 shs

Average Volume

7,392,476 shs

Market Capitalization

$3.62 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.